Over the past 10 years, stimuli-responsive polymeric biomaterials have emerged as effective systems for the delivery of therapeutics. Persistent with ongoing efforts to minimize adverse effects, stimuli-responsive biomaterials are designed to release in response to either chemical, physical, or biological triggers. The stimuli-responsiveness of smart biomaterials may improve spatiotemporal specificity of release. The material design may be used to tailor smart polymers to release a drug when particular stimuli are present. Smart biomaterials may use internal or external stimuli as triggering mechanisms. Internal stimuli-responsive smart biomaterials include those that respond to specific enzymes or changes in microenvironment pH; external stimuli can consist of electromagnetic, light, or acoustic energy; with some smart biomaterials responding to multiple stimuli. This review looks at current and evolving stimuli-responsive polymeric biomaterials in their proposed applications.
16 April 2019 in IEEE Transactions on Biomedical Engineering
In the last several years, conventional Drug Delivery Systems (DDS) have evolved into DDS that are responsive to exogenous or endogenous stimuli. The objective of this work was to present a DDS that is responsive to an electric stimulus, in the form of bipolar electric pulses. The DDS structure is based on chitosan embedded with magnetic nanoparticles, and crosslinked with polyethylene glycol dimethacrylate to form microbeads. This DDS is loaded with vancomycin as the therapeutic agent of interest. Silver Inter-Digitated Electrodes (IDE) were printed on Polyimide substrates with a MEMS-based inkjet material deposition printer, and used to provide 100 Hz pulses of electric current to the DDS for 3 min. The results showed that the stimulated groups released ∼800% more vancomycin than the non-stimulated groups in the excitation duration, but followed a first-order elution profile otherwise. Another significance of our approach is that it does not need complicated or expensive fabrication processes, and can be customized according to the targeted implant site. The IDE system has also been modeled using COMSOL® to study the distributed electric fields and ion migration during the stimulus. This work demonstrates a novel and promising technique of providing stimulus to drug substrates for controllable drug delivery.
Chitosan nanofiber membranes are recognized as functional antimicrobial materials, as they can effectively provide a barrier that guides tissue growth and supports healing. Methods to stabilize nanofibers in aqueous solutions include acylation with fatty acids. Modification with fatty acids that also have antimicrobial and biofilm-resistant properties may be particularly beneficial in tissue regeneration applications. This study investigated the ability to customize the fatty acid attachment by acyl chlorides to include antimicrobial 2-decenoic acid. Synthesis of 2-decenoyl chloride was followed by acylation of electrospun chitosan membranes in pyridine. Physicochemical properties were characterized through scanning electron microscopy, FTIR, contact angle, and thermogravimetric analysis. The ability of membranes to resist biofilm formation by S. aureus and P. aeruginosa was evaluated by direct inoculation. Cytocompatibility was evaluated by adding membranes to cultures of NIH3T3 fibroblast cells. Acylation with chlorides stabilized nanofibers in aqueous media without significant swelling of fibers and increased hydrophobicity of the membranes. Acyl-modified membranes reduced both S.aureus and P.aeruginosa bacterial biofilm formation on membrane while also supporting fibroblast growth. Acylated chitosan membranes may be useful as wound dressings, guided regeneration scaffolds, local drug delivery, or filtration.